Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Alembic Pharmaceuticals Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (320)
ARTG (171)
Prescription medicine registration (8)

Date

2024 (12)
2023 (257)
2022 (10)
2021 (84)
2020 (22)
2019 (2)
2018 (27)
2017 (48)
2016 (3)
2015 (11)
2013 (17)
2012 (6)

Results for "[search-keyword]"

Search

Sponsor content

499 result(s) found, displaying 51 to 60

ALEMBIC OSELTAMIVIR oseltamivir (as phosphate) 30 mg hard capsule blister pack (377302)

17 November 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ALEMBIC OSELTAMIVIR oseltamivir (as phosphate) 30 mg hard capsule blister pack.
DESVENLAFAXINE ALEMBIC desvenlafaxine 50 mg extended release tablet blister pack (379767)

10 November 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for DESVENLAFAXINE ALEMBIC desvenlafaxine 50 mg extended release tablet blister pack.
DESVENLAFAXINE ALEMBIC desvenlafaxine 100 mg extended release tablet blister pack (379751)

10 November 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for DESVENLAFAXINE ALEMBIC desvenlafaxine 100 mg extended release tablet blister pack.
CANDESARTAN HCTZ AGL 16/12.5 candesartan cilexetil 16 mg & hydrochlorothiazide 12.5 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

16 February 2023

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
DEFERASIROX AGHL deferasirox 360 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

16 February 2023

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
VIMOLAC lacosamide 100 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

16 February 2023

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
CANDESARTAN HCTZ APA 16/12.5 candesartan cilexetil 16 mg & hydrochlorothiazide 12.5 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

13 February 2023

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
CANDESARTAN HCTZ AGL 32/25 candesartan cilexetil 32 mg & hydrochlorothiazide 25 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

13 February 2023

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
CANDESARTAN HCTZ AGL 32/12.5 candesartan cilexetil 32 mg & hydrochlorothiazide 12.5 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

13 February 2023

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd
CANDESARTAN HCTZ AGL 16/12.5 candesartan cilexetil 16 mg & hydrochlorothiazide 12.5 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

13 February 2023

Cancellation by sponsor

Requested by Alembic Pharmaceuticals Australia Pty Ltd

Pages

First page
Previous page
…
Page 2
Page 3
Page 4
Page 5
Current page 6
Page 7
Page 8
Page 9
Page 10
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.